Renal Cancer - Results from #1980

A microRNA-clinical prognosis model to predict the overall survival for kidney renal clear cell carcinoma. July 30, 2021

Long-term outcomes of CT-guided percutaneous cryoablation of T1a and T1b renal cell carcinoma. July 29, 2021

Role of Radioembolization in the Management of Liver-Dominant Metastatic Renal Cell Carcinoma: A Single-Center, Retrospective Study. July 29, 2021

Sarcomatoid features and lymph node-positive disease in chromophobe renal cell carcinoma. July 28, 2021

Renal mass biopsy: A strategy to reduce associated costs and morbidity when managing localized renal masses. July 28, 2021

Pathology and systemic therapy of non-clear cell renal cell carcinoma: an overview. July 27, 2021

Prognostic value of programmed death-ligand 1 status in Japanese patients with renal cell carcinoma. July 27, 2021

Comprehensive Analysis of Ferroptosis Regulators With Regard to PD-L1 and Immune Infiltration in Clear Cell Renal Cell Carcinoma. July 26, 2021

Rate of incisional hernia after minimally invasive and open surgery for renal cell carcinoma: a nationwide population-based study. July 26, 2021

Evolving biological associations of upfront cytoreductive nephrectomy in metastatic renal cell carcinoma. July 23, 2021

Comparison of robot-assisted partial nephrectomy for complex (RENAL scores ≥10) and non-complex renal tumors: A single-center experience. July 22, 2021

Presence of Urinary Exosomes for Liquid Biopsy of Clear Cell Renal Cell Carcinoma: Protocol for a Pilot Feasibility Study. July 22, 2021

Role of Imaging in Renal Cell Carcinoma: A Multidisciplinary Perspective. July 21, 2021

Kidney Transplant Outcomes in Indigenous People of the Northern Great Plains of the United States. July 21, 2021

Immune-based combinations for the treatment of metastatic renal cell carcinoma: a meta-analysis of randomised clinical trials. July 20, 2021

Prevalence and Landscape of Actionable Genomic Alterations in Renal Cell Carcinoma. July 20, 2021

Haplotype-resolved germline and somatic alterations in renal medullary carcinomas. July 20, 2021

Evaluation of Insurance Coverage and Cancer Stage at Diagnosis Among Low-Income Adults With Renal Cell Carcinoma After Passage of the Patient Protection and Affordable Care Act. July 19, 2021

Serum and urine analysis with gold nanoparticle-assisted laser desorption/ionization mass spectrometry for renal cell carcinoma metabolic biomarkers discovery. July 19, 2021

Cystatin C predicts renal function impairment after partial or radical tumor nephrectomy. July 19, 2021

Page 100 of 459